This health economic study1 demonstrated that oral nutritional supplements provided during hospitalization were associated with decreased length of stay and episode costs. In patients with at least one known follow-up, there was a 6.7% decrease in probability of 30-day hospital readmissions.*
A retrospective health economic study was conducted to assess the association and impact of ONS on health outcomes for hospitalized patients. The retrospective analysis utilized information from more than one million adult inpatient cases found in the 2000-2010 Premier Research Database maintained by the Premier healthcare alliance —representing a total of 44 million hospital episodes from across the United States or approximately 20 percent of all inpatient admissions in the U.S.
The study’s three key outcome variables were LOS, episode cost, and probability of 30-day readmission. LOS was defined as the number of days of direct patient care from admission to discharge. Episode cost was defined as the actual costs to treat the patient during the hospitalization. Probability of 30-day readmission was defined as a return hospitalization for any diagnosis to a Premier hospital. ONS was defined as a complete oral nutritional supplement, as indicated by the Premier data.
This study is the first health economic study designed to measure the impact of oral nutritional supplements on hospital outcomes.
The study results included 44.0 million episodes and 724,027 ONS episodes. The overall rate of ONS use in adult inpatient episodes was 1.6 percent. Each adult ONS episode was matched to an adult non-ONS episode that accounted for differences in age, illness acuity, and demographics, to obtain a matched sample of 1,160,088 episodes.
The results of this study demonstrated that oral nutritional supplements provided during hospitalization were associated with a:
There was a 6.7% decrease in probability of 30-day hospital readmissions in patients with at least one known follow-up.*
The study has two key advantages over previous research. First, it used a large database to estimate the effect of ONS based on real-world data. With 44 million adult inpatient episodes, these data were relevant and broadly representative. Second, econometric methods were employed to examine the impact of ONS on patient outcomes. By matching ONS and non-ONS episodes, potential bias due to nonrandom selection into ONS treatment was eliminated. This made it possible to estimate the impact of ONS use on LOS, episode cost, and 30-day readmission probability.
This study found that the use of oral nutritional supplements was associated with statistically significant decreases in inpatient length of stay and episode cost. In patients with at least one known follow-up, the probability of 30-day readmission was also decreased. Given the high prevalence of malnutrition among inpatient populations, these results suggest that oral nutritional supplementation could help decrease hospitalization costs.
The study was published in the February 2013 issue of the American Journal of Managed Care.